There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:GENENTECH, INC.
Subcategories
This category has the following 28 subcategories, out of 28 total.
C
D
E
F
H
I
J
L
M
N
O
R
S
T
U
V
Y
Z
Pages in category "GENENTECH, INC."
The following 18 pages are in this category, out of 18 total.
1
- 18420510. ISOFORM-SELECTIVE ANTI-TGF-BETA ANTIBODIES AND METHODS OF USE simplified abstract (GENENTECH, INC.)
- 18566257. CYCLIC PEPTIDE ANTIBIOTICS simplified abstract (GENENTECH, INC.)
- 18636947. CELL-BASED ASSAY FOR DETECTING ANTl-CD3 HOMODIMERS simplified abstract (GENENTECH, INC.)
- 18647560. SYSTEMS AND METHODS TO IDENTIFY MHC-ASSOCIATED ANTIGENS FOR THERAPEUTIC INTERVENTION simplified abstract (GENENTECH, INC.)
- 18648653. DUAL SPECIFIC ANTIBODIES simplified abstract (GENENTECH, INC.)
- 18659241. COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR simplified abstract (GENENTECH, INC.)
- 18682046. FLOW THROUGH CATION EXCHANGE CHROMATOGRAPHY PURIFICATION PROCESSES FOR ANTIBODY DRUG CONJUGATES simplified abstract (GENENTECH, INC.)
- 18927265. ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOF (GENENTECH, INC.)
- 18983995. Anti-Polyubiquitin Multispecific Antibodies (GENENTECH, INC.)
- 18984106. COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR (GENENTECH, INC.)
- 18985661. OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS (GENENTECH, INC.)
- 18991315. Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof (GENENTECH, INC.)